Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Chemotherapy patient challenges NHS fertility preservation funding refusal

14 April 2014

By Cait McDonagh

Appeared in BioNews 750

A Crohn's disease patient is challenging a decision to refuse her funding for her eggs to be cryopreserved before she undergoes a bone marrow transplant and chemotherapy. The 'exceptionally urgent' case is currently being decided by Mr Justice Jay at the High Court in London.

Lizzy Rose, from Margate in Kent, had applied three times for funding to have her eggs cryopreserved before she undergoes treatment for Crohn's disease. Rose fears the treatment will leave her infertile and unable to have genetic children of her own.

Thanet Clinical Commissioning Group (CCG) had 'continually refused' to provide the NHS-funded treatment according to Rose's barrister, Jeremy Hyam. In his written argument, Hyam says that the policy was unlawful and out of date.

Rose faces 'imminent' treatment for the disease, after being diagnosed when she was 14. The procedures for egg cryopreservation take a few weeks to complete, and therefore there is a 'short window of opportunity', said Hyam. 'The expected consequence for her, if the fertility preservation treatment is not provided, is lifelong infertility and the inability to bear her own genetic child'.

The treatment, which would cost £4,050, is currently available to couples and to single men. Hyam accordingly called the refusal 'discriminatory'. Single woman are eligible for the treatment in other areas of the UK, leading Rose to believe that she’s the victim of a 'postcode lottery'.

Thanet CCG is contesting the case and said in a statement: 'The policy all Kent and Medway CCGs have adopted, after extensive consultation and clinical advice, is that this particular procedure will not normally be funded [...] on the basis that there is insufficient evidence to demonstrate effectiveness'.

'We are very sorry about the distress this may cause patients who are facing very difficult personal circumstances. However, we must use our limited public money to fund services for our population as a whole and so are required to take difficult decisions on prioritising treatments'.

In a statement, Rose's solicitors counter that 'NICE [the National Institute for Health and Care Excellence] reviewed the clinical evidence and cost-effectiveness of this treatment and has recommended it should be offered'.

'Thanet CCG provides funding for fertility preservation for males and couples, also recommended by NICE on similar terms. It cannot be right to not fund this treatment for women like Lizzy'.

A decision is expected on Wednesday 16 April.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

09 March 2015 - by Meghna Kataria 
A drug can reduce the risk of infertility and early menopause in women undergoing chemotherapy for certain early stage breast cancers...
24 November 2014 - by Isobel Steer 
The majority of young breast cancer patients are not being referred for treatment which could preserve their fertility after chemotherapy, says a UK charity...
28 July 2014 - by Ruth Retassie 
Mid Essex Clinical Commissioning Group has proposed to limit access to IVF to cancer patients and HIV-positive men under its options for reform to the funding of its fertility services....
19 May 2014 - by Rebecca Carr 
The National Institute for Health and Care Excellence has published a set of draft statements that aim to 'eliminate' current geographical disparities in access to fertility treatment...
28 April 2014 - by Merry Varney 
In the recent case of R (on the application of Elizabeth Rose) v Thanet CCG, in which I was instructed by Elizabeth Rose, the High Court was asked to consider whether a policy denying funding for cryopreservation of oocytes – a treatment recommended by the National Institute for Health and Care Excellence (NICE) – was lawful....

29 July 2013 - by Dr James Heather 
Despite treatment for childhood cancer causing an increased risk of infertility, most women still manage to conceive, research has shown...
01 October 2012 - by Emma Stoye 
Two proteins that kick-start the destruction of damaged mouse eggs have been discovered by scientists. The findings may go on to have applications in fertility preservation for female cancer patients who receive aggressive treatment...
11 June 2012 - by Valerie Peddie 
Major professional bodies support the concept of providing every patient of reproductive age with accurate information about the potential risk of impaired fertility after treatment for cancer. In reality, the immediate emphasis is often on treatment, with little time available to discuss options for fertility preservation...
23 October 2007 - by Dr Kirsty Horsey 
US fertility doctors have issued new guidelines recommending that women should not be able to freeze their eggs if there are no health indications for doing so. Women who are worried about not finding the right partner or who deliberately delay having children should not be...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation